{
  "id": 354,
  "text": "HPV testing or co-testing is preferred than cytology in the follow up management after histologic HSIL treatment, as it provides the most accurate predictor of treatment outcome.Using HPV testing or co-testing, $91 \\%$ ( $9 5 \\%$ CI 82- $9 6 \\%$ ) of residual or recurrent $\\mathrm { C I N } 2 +$ was predicted, regardless of margins status (68).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: HPV testing or co-testing is preferred than cytology in the follow up management after histologic HSIL treatment, as it provides the most accurate predictor of treatment outcome.Using HPV testing or co-testing, $91 \\%$ ( $9 5 \\%$ CI 82- $9 6 \\%$ ) of residual or recurrent $\\mathrm { C I N } 2 +$ was predicted, regardless of margins status (68).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在HSIL治疗后的随访管理中，HPV检测或联合检测优于细胞学检查的主要原因在于其对治疗结果的预测更为准确。研究显示，无论病变切缘状态如何，HPV检测或联合检测能够预测91%（95% CI：82%-96%）的残留或复发的CIN2+病变。这种高敏感性使其在监测病变复发以及评估治疗效果方面，比单独依赖细胞学检查更具优势。因此，在随访过程中，推荐使用HPV检测或联合检测作为主要手段。",
  "query": "在HSIL治疗后随访管理中，HPV检测或联合检测为何优于细胞学检查？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在HSIL治疗后随访管理中，HPV检测或联合检测为何优于细胞学检查？\n\n<reference text>: HPV testing or co-testing is preferred than cytology in the follow up management after histologic HSIL treatment, as it provides the most accurate predictor of treatment outcome.Using HPV testing or co-testing, $91 \\%$ ( $9 5 \\%$ CI 82- $9 6 \\%$ ) of residual or recurrent $\\mathrm { C I N } 2 +$ was predicted, regardless of margins status (68).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在HSIL治疗后的随访管理中，HPV检测或联合检测优于细胞学检查的主要原因在于其对治疗结果的预测更为准确。研究显示，无论病变切缘状态如何，HPV检测或联合检测能够预测91%（95% CI：82%-96%）的残留或复发的CIN2+病变。这种高敏感性使其在监测病变复发以及评估治疗效果方面，比单独依赖细胞学检查更具优势。因此，在随访过程中，推荐使用HPV检测或联合检测作为主要手段。"
}